Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Watanabe

Showing results (321-330 of 510) with videos related to

Pageof 51
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular cloneNorio Maeda, Mamoru Watanabe, Susumu Okamoto, et al.
Journal of Gastroenterology|December 24, 2013
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitisYasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.
Biochemical and Biophysical Research Communications|December 16, 2003
Specific inhibition of hepatitis C virus replication by cyclosporin AMina Nakagawa, Naoya Sakamoto, Nobuyuki Enomoto, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|January 10, 2017
Surveillance for dysplasia in patients with ulcerative colitis: Discrepancy between guidelines and practiceMasaru Shinozaki, Kiyonori Kobayashi, Reiko Kunisaki, et al.
Journal of Gastroenterology and Hepatology|August 19, 2021
Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitisMakoto Naganuma, Kenji Watanabe, Satoshi Motoya, et al.
Hepatology International|April 13, 2011
Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapyMakoto Kadokura, Shinya Maekawa, Ryota Sueki, et al.
Inflammatory Intestinal Diseases|September 18, 2018
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance TherapySatoshi Motoya, Mamoru Watanabe, Kori Wallace, et al.
Plos One|September 22, 2011
Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapyMakoto Kadokura, Shinya Maekawa, Ryota Sueki, et al.
Plos One|February 13, 2014
Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesisMasahiro Suzuki, Takashi Nagaishi, Motomi Yamazaki, et al.
Gastroenterology|August 2, 2012
T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in miceYuichi Ono, Takanori Kanai, Tomohisa Sujino, et al.
Pageof 51

Showing results (321-330 of 510) with videos related to

Sort By:
Pageof 51
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular cloneNorio Maeda, Mamoru Watanabe, Susumu Okamoto, et al.
Journal of Gastroenterology|December 24, 2013
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitisYasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.
Biochemical and Biophysical Research Communications|December 16, 2003
Specific inhibition of hepatitis C virus replication by cyclosporin AMina Nakagawa, Naoya Sakamoto, Nobuyuki Enomoto, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|January 10, 2017
Surveillance for dysplasia in patients with ulcerative colitis: Discrepancy between guidelines and practiceMasaru Shinozaki, Kiyonori Kobayashi, Reiko Kunisaki, et al.
Journal of Gastroenterology and Hepatology|August 19, 2021
Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitisMakoto Naganuma, Kenji Watanabe, Satoshi Motoya, et al.
Hepatology International|April 13, 2011
Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapyMakoto Kadokura, Shinya Maekawa, Ryota Sueki, et al.
Inflammatory Intestinal Diseases|September 18, 2018
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance TherapySatoshi Motoya, Mamoru Watanabe, Kori Wallace, et al.
Plos One|September 22, 2011
Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapyMakoto Kadokura, Shinya Maekawa, Ryota Sueki, et al.
Plos One|February 13, 2014
Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesisMasahiro Suzuki, Takashi Nagaishi, Motomi Yamazaki, et al.
Gastroenterology|August 2, 2012
T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in miceYuichi Ono, Takanori Kanai, Tomohisa Sujino, et al.
Pageof 51